February 6, 2023 – MeniscusTears.com
This study was conducted to identify factors that increase the probability that a patient’s meniscal repair will be successful.
The researchers reviewed the medical records of 119 patients who had undergone meniscal repair.
The researchers looked at many different factors including the age at time of injury, time between injury and meniscal repair, location and size of tear, knee function, and severity of osteoarthritis. The repair was considered successful if, during follow-up appointments, the patient did not have pain that interfered with activity or have knee catching/locking/giving away or significant swelling, and if the patient did not require further surgery on the repaired meniscus.
Medical records were reviewed for 6 years post-surgery, on average.
This study shows that arthroscopic meniscal repair has a very high success rate, especially in younger patients, and for those whose repair is done within 6 weeks of injury.
Save your meniscus to prevent future surgeries and health issues by repairing it with the FDA approved NovoStitch Pro Meniscal Repair System invented by Dr. Saliman.
Dr. Justin Saliman, a seasoned knee orthopedic surgeon, invented the Edison Award winning “Novo Stitch Pro Meniscal Repair System” to arthroscopically sew back all meniscus tear types – including those previously considered difficult or impossible to sew.
Minimally-invasive, the system involves a “Circumferential Stitching Technique” that has proven superior to traditional meniscus repair techniques. As a result, patients heal pain and dysfunction while preventing arthritis and knee surgical replacement in the long-term.
We’re focused on making our website accessible and functional for all our users, including those who may have disabilities. In doing so, we look to the web content accessibility guidelines (“wcag”) 2.0, levels a and aa. We primarily use automated tools to assist in assessing and in improving the accessibility of our website. We view accessibility as an ongoing effort, and if you encounter an accessibility issue, please contact us at +1 (310) 703-5819 to work with you to resolve the issue.
Justin D. Saliman, MD, located in Beverly Hills, is a Stanford sports medicine trained orthopaedic surgeon operating out of Cedars-Sinai Hospital in Los Angeles.
He is the founder of Ceterix® Orthopaedics and the inventor of the NovoStitch® Pro Meniscal Repair System, which was acquired by a large medical device company called Smith & Nephew in 2019.
The device was granted FDA approval in 2012 and Dr. Saliman has been using it to preserve knee joints ever since.
Nobody has more experience sewing meniscus tears
back together than Dr. Saliman.
He is specialized in joint preserving minimally invasive techniques to repair injuries to the knee to prevent arthritis and the need for joint replacement later in life.
Dr. Saliman completed a sports medicine fellowship at Stanford University in Palo Alto, California, where he cared for the San Francisco 49ers and the athletic teams at Santa Clara and Stanford Universities.
Prior to his fellowship, he completed his orthopaedic surgery residency at the prestigious St. Luke’s-Roosevelt Hospital Center of Columbia University in New York City. He earned his medical degree at the University of Colorado School of Medicine outside his hometown of Denver.